Management of type 2 diabetes in older people

Diabetes Therapy

Volumn 4, Issue 1, 2013, Pages 13-26

  Abdelhafiz, Ahmed H ^a   Sinclair, Alan J ^b  

^a ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

Author keywords

Diabetes mellitus; Geriatric assessment; Glycemic targets; Management; Older people; Type 2 diabetes

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; MEGLITINIDE; METFORMIN; PIOGLITAZONE; SULFONYLUREA DERIVATIVE;

ABDOMINAL PAIN; AGED; CARDIOVASCULAR RISK; COMORBIDITY; DIABETES MELLITUS; DIARRHEA; FOLLOW UP; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; MORBIDITY; MORTALITY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYPHARMACY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY; URINE INCONTINENCE; VERY ELDERLY;

EID: 84886780136     PISSN: 18696953     EISSN: 18696961     Source Type: Journal    
DOI: 10.1007/s13300-013-0020-4     Document Type: Review

References (54)

1. Liu L. Changes in cardiovascular hospitalization and comorbidity of Heart failure in the United States: findings from the national hospital discharge surveys 1980-2006. Int J Cardiol. 2011;149:39-45.
2. Valiyeva E, Russell LB, Miller JE, Safford MM. Lifestyle-related risk factors and risk of future nursing home admission. Arch Intern Med. 2006;166:985-990.
3. Wild S, Roglic G, Green A, Sicree A, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
4. Ricci P, Blotière PO, Weill A, et al. Diabète traité en France: quelles évolutions entre 2000 et 2009? Bull Epidemiol Hebd. 2010;43:425-431.
5. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29.
6. Cowie C, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care. 2009;32:287-294.
7. Aspray TJ, Nesbit K, Cassidy TP, Farrow E, Hawthorne G. Diabetes in British nursing and residential homes: a pragmatic screening study. Diabetes Care. 2006;29:707-708.
8. Resnick HE, Heineman J, Stone R, Shorr RI. Diabetes in US nursing homes, 2004. Diabetes Care. 2008;31:287-288.
9. Zhang X, Decker FH, Luo H, et al. Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995-2004. J Am Geriatr Soc. 2010;58:724-730.
10. Dybicz SB, Thompson S, Molotsky S, Stuart B. Prevalence of diabetes and the burden of comorbid conditions among elderly nursing home residents. Am J Geriatr Pharmacother. 2011;9:212-223.
11. Nieto-Vazquez I, Fernandez-Veledo S, Kramer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem. 2008;114:183-194.
12. Evans WJ. Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr. 2010; 91:1123S-1127S.
13. Szoke E, Shrayyef MZ, Messing S, et al. Effect of aging on glucose homeostasis: accelerated deterioration of b-cell function in individuals with impaired glucose tolerance. Diabetes Care. 2008;31:539-43.
14. Meneilly GS, Tessier D. Diabetes in the elderly. In: Morley JE, van den Berg L, eds. Contemporary endocrinology, endocrinology of aging. Totowa, NJ: Humana Press; 2000. p. 181-203.
15. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2002;25(Suppl 1):S5-S20.
16. Barzilay JI, Spiekerman CF, Wahl PW. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet. 1999;354:622-625.
17. Sinclair AJ, Gadsby R, Penfold S, Croxson SC, Bayer AJ. Prevalence of diabetes in care home residents. Diabetes Care. 2001;24:1066-1068.
18. Peter A, Fritsche A, Stefan N, Heni M, Häring HU, Schleicher E. Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk. Exp Clin Endocrinol Diabetes. 2011; 119:234-237.
19. Maddigan SL, Feeny DH, Johnson JA. Healthrelated quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Qual Life Res. 2005;14:1311-1320.
20. Duffy RE, Mattson BJ, Zack M. Comorbidities among Ohio's nursing home residents with diabetes. J Am Med Dir Assoc. 2005;6:383-389.
21. Gadsby R, Barker P, Sinclair A. People living with diabetes resident in nursing homes-assessing levels of disability and nursing needs. Diabet Med. 2011;28:778-780.
22. Gadsby R, Barker P, Sinclair A. Death rate of residents with diabetes in nursing homes. Diabet Med. 2011;28:829-830.
23. Tierney EF, Cadwell BL, Engelgau MM, et al. Declining mortality rate among people with diabetes in North Dakota, 1997-2002. Diabetes Care. 2004;27:2723-2725.
24. Munshi M, Grande L, Hayes M, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care. 2006;29:1794-1799.
25. Gregg EW, Engelgau MM, Narayan V. Complications of diabetes in elderly people. BMJ. 2002;325:916-917.
26. Volpato S, Bianchi L, Lauretani F, et al. Role of muscle mass and muscle quality in the association between diabetes and gait speed. Diabetes Care. 2012;35:1672-9.
27. Morley JE, Perry HM, Miller DK. Something about frailty. J Gerontol A Biol Sci Med Sci. 2002;57: M698-M704.
28. Kahn AJ. Central and peripheral mechanisms of aging and frailty: a report on the 8th Longevity Consortium Symposium, Santa Fe, New Mexico, May 16-18, 2007. J Gerontol A Biol Sci Med Sci. 2007;62:1357-1360.
29. Egede LE. Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes. Psychosom Med. 2005;67:46-51.
30. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-years follow-up of intensive glucose control in Type 2 diabetes. N Engl J Med. 2008;359:1577-1589.
31. Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559.
32. ADVANCE Collaborative Group; Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-2572.
33. Duckworth W, Abraira C, Mortiz T, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129-139.
34. Launer LJ, Miller ME, Williamson JD, et al. ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969-977.
35. Pham M, Pinganaud G, Richard-Harston S, Decamps A, Bourdel-Marchasson I. Prospective audit of diabetes care and outcomes in a group of geriatric French care homes. Diabetes Metab. 2003;29:251-258.
36. Nelson JM, Dufraux K, Cook PF. The relationship between glycaemic control and falls in older adults. J Am Geriatr Soc. 2007;55:2041-2044.
37. Huang ES, Zhang Q, Gandra N, Chin MH, Meltzer DO. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis. Ann Intern Med. 2008;149:11-19.
38. American Diabetes Association. Executive summary: standards of medical care in diabetes- 2010. Diabetes Care. 2010;33:S4-S10.
39. Abdelhafiz AH, Sinclair AJ. Tailor treatment in the older patient with type 2 diabetes. Practitioner. 2013;257:21-25.
40. Kronmal RA, Barzilay JI, Smith NL, et al. Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989-2001. PLoS Med. 2006;3:e400.
41. Blaum CS, Volpato S, Cappola AR, et al. Diabetes, hyperglycaemia and mortality in disabled older women: the Women's Health and Ageing Study I. Diabet Med. 2005;22:543-550.
42. Schwartz AV, Vittinghoff E, Sellmeyer DE, et al; Health, Aging, and Body Composition Study. Diabetes-related complications, glycaemic control, andfalls in olderadults. DiabetesCare. 2008;31:391-396.
43. Huang ES, Liu JY, Moffet HH, John PM, Karter AJ. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care. 2011;34:1329-1336.
44. Cox DJ, Kovatchev BP, Gonder-Frederick LA, et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care. 2005;28:71-77.
45. Lee SJ, Eng C. Goals of glycemic control in frail older patients with diabetes. JAMA. 2011;305:1350-1351.
46. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42:484-491.
47. Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol. 2009;66: 1210-1215.
48. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64-74.
49. Feil DG, Zhu CW, Sultzer DL. The relationship between cognitive impairment and diabetes selfmanagement in a population-based community sample of older adults with Type 2 diabetes. J Behav Med. 2012;35:190-1909.
50. Bruce DG, Davis WA, Casey GP, et al. Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia. 2009;52:1808-1815.
51. Sinclair A, Armes DG, Randhawa G, Bayer AJ. Caring for older adults with diabetes mellitus: characteristics of carers and their prime roles and responsibilities. Diabet Med. 2010;27:1055-1059.
52. Rosentock J, Daily G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Reduced hypoglycaemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care. 2005;28:950-956.
53. Abdelhafiz AH, Sinclair AJ. Hypoglycemia in residential care homes. Br J Gen Pract. 2009;59: 49-50.
54. Bramlage P, Gitt AK, Binz C, Krekler M, Deeg E, Tschöpe D. Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycaemia. Cardiovasc Diabetol. 2012;11:122.